Stakeholder Meeting on the transferable data exclusivity voucher (TDEV) for priority antimicrobials

Information session on implementation aspects of the transferable data exclusivity voucher for priority antimicrobials as laid out in the new pharmaceutical legislation.

• Datum:
  Čtvrtek, 12 Listopad 2026 , 14:00 - 17:00 Amsterdam time (CET)
• Místo:
  Online
  Live broadcast

Event summary

A transferable data exclusivity voucher (TEV) supports investment in new treatments for antimicrobial-resistant infections, a major global public health challenge.

A TEV allows its holder to extend the regulatory data protection of a centrally authorised medicinal product by 12 months. The voucher may be used for the priority antimicrobial that qualifies for the incentive or for another product held by the same or a different marketing authorisation holder.

What participants learn

This meeting provides an overview of the practical implementation of the TEV, including:

• Eligibility criteria for a priority antimicrobial
• Scientific assessment requirements
• Conditions for requesting a voucher
• Key elements of the related guidance

Registration

The meeting will be broadcast live. Registration for virtual participation by invitation only. 

A video recording will be published after the event.

Documents

Agenda - Stakeholder meeting, November 2026